iNtRON Biotechnology, Inc. (KOSDAQ:048530)

iNtRON Biotechnology Revenue

In the year 2025, iNtRON Biotechnology had annual revenue of 5.74B KRW, down -10.56%. iNtRON Biotechnology had revenue of 1.70B in the quarter ending December 31, 2025, with 12.02% growth. That makes iNtRON Biotechnology the 40,489th largest company in the world by revenue and 2,505th in South Korea.

• Revenue: 5.74B
• Revenue Growth: -10.56%
• P/S Ratio: 15.01
• Revenue / Employee: 78.63M
• Employees: 73
• Market Cap: 86.34B

Revenue Chart

Chart

Chart

Revenue by Geography

Chart

• South Korea 4.44B 77.3%
• Export 1.30B 22.7%

Fiscal year ended Dec 31, 2025 See the full iNtRON Biotechnology breakdown

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	5.74B	-677.59M	-10.56%
Dec 31, 2024	6.42B	-3.17B	-33.05%
Dec 31, 2023	9.59B	-4.42B	-31.57%
Dec 31, 2022	14.01B	-15.30B	-52.21%
Dec 31, 2021	29.31B	-16.13B	-35.49%

Data Source: S&P Global Market Intelligence Last updated: Mar 11, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Oct 28, 2026

Data Sources Report a data error